Due to health issues, this site is no longer maintained and will be shut down shortly. |
BioPlus Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its search on companies in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York. This security was issued by BioPlus Acquisition Corp. Class A, whose common stock symbol is BIOS.
$0.11
As of 07/08/2022 IEX book CBOE book
2022 © Stock Market MBA, Inc.